The Department of Justice (DOJ) moved certain medical marijuana products to Schedule III, broadening workplace rights and employer ...
On Friday, the Food and Drug Administration announced a new pilot prioritization program for the review of abbreviated new drug applications that aims to spur and reward investment in U.S. drug ...